OpenURL Connection Search

Select item for more details and to access through your institution.

A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO‐idel).
Published in:
British Journal of Haematology, 2021, v. 194, n. 1, p. 69, doi. 10.1111/bjh.17475
By:
- Eyre, Toby A.;
- Preston, Gavin;
- Kagdi, Huseini;
- Islam, Amin;
- Nicholson, Toby;
- Smith, Harry W.;
- Cursley, Adam P.;
- Ramroth, Heribert;
- Xing, Guan;
- Gu, Lin;
- Rajakumaraswamy, Nishanthan;
- Fegan, Christopher
Publication type:
Article
A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products ( ATMPs).
Published in:
British Journal of Clinical Pharmacology, 2013, v. 76, n. 2, p. 203, doi. 10.1111/bcp.12057
By:
- Jones, David R.;
- McBlane, James W.;
- McNaughton, Graham;
- Rajakumaraswamy, Nishanthan;
- Wydenbach, Kirsty
Publication type:
Article
Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 4, p. 260, doi. 10.1016/j.clml.2023.12.008
By:
- Rajakumaraswamy, Nishanthan;
- Gandhi, Mitul;
- Wei, Andrew H.;
- Sallman, David A.;
- Daver, Naval G.;
- Mo, Shuyuan;
- Iqbal, Shahed;
- Karalliyadda, Roshan;
- Chen, Manli;
- Wang, Yunfei;
- Vyas, Paresh
Publication type:
Article
Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis.
Published in:
2023
By:
- Hasegawa, Ken;
- Wei, Andrew H;
- Garcia-Manero, Guillermo;
- Daver, Naval G;
- Rajakumaraswamy, Nishanthan;
- Iqbal, Shahed;
- Chan, Rebecca J;
- Hu, Hao;
- Tse, Preston;
- Yan, Jiajun;
- Zoratti, Michael J;
- Xie, Feng;
- Sallman, David A
Publication type:
journal article
Retrospective Analysis of the Impact of Adverse Event–Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e432, doi. 10.1016/j.clml.2020.12.016
By:
- Shuo Ma;
- Chan, Rebecca J.;
- Lin Gu;
- Guan Xing;
- Rajakumaraswamy, Nishanthan;
- Ruzicka, Bianca B.;
- Wagner-Johnston, Nina D.
Publication type:
Article
α2-Adrenoceptor agonists: shedding light on neuroprotection?
Published in:
British Medical Bulletin, 2004, v. 71, n. 1, p. 77, doi. 10.1093/bmb/ldh036
By:
- Ma, Daqing;
- Rajakumaraswamy, Nishanthan;
- Maze, Mervyn
Publication type:
Article
Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants.
Published in:
CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70011
By:
- Dauki, Anees M.;
- Rajakumaraswamy, Nishanthan;
- Trowe, Torsten;
- Weng, Winnie;
- Lin, Kai‐Wen;
- Elboudjwarej, Emon;
- Qin, Ann Ran‐Ran;
- Schwabe, Christian;
- Kuhne, Michelle R.;
- Othman, Ahmed A.
Publication type:
Article
A Phase Ib Study of Single‐Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Published in:
Oncologist, 2020, v. 25, n. 11, p. e1604, doi. 10.1634/theoncologist.2020-0321
By:
- Borazanci, Erkut;
- Pishvaian, Michael J.;
- Nemunaitis, John;
- Weekes, Colin;
- Huang, Julie;
- Rajakumaraswamy, Nishanthan
Publication type:
Article

Found: 8